Submission Details
| 510(k) Number | K213427 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 21, 2021 |
| Decision Date | November 22, 2022 |
| Days to Decision | 397 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K213427 is an FDA 510(k) clearance for the PRIMED Pediatric Facemask, a Pediatric/child Facemask (Class II — Special Controls, product code OXZ), submitted by Primed Medical Products, Inc. (Edmonton, CA). The FDA issued a Cleared decision on November 22, 2022, 397 days after receiving the submission on October 21, 2021. This device falls under the General Hospital review panel. Regulated under 21 CFR 878.4040.
| 510(k) Number | K213427 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 21, 2021 |
| Decision Date | November 22, 2022 |
| Days to Decision | 397 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | OXZ — Pediatric/child Facemask |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4040 |
| Definition | A Pediatric/child Facemask Is Intended To Be Worn By The Patient/child To Provide Protection For The Respiratory Tract. It Is A Single Use, Disposable Device That Is Provided Non-sterile. The Facemask Is Recommended For Use In A Healthcare Setting With Appropriate Adult Supervision. |